They work to prevent disease in the first place, as well as change the course of a disease. Their broad portfolio and pipeline continue to strengthen, with key milestones across core therapeutic areas, whilst new, critical avenues of discovery continue to be discovered in partnership with institutions such as the University of Oxford, Kings College London on cancer treatment and 23andMe.  

They have bold ambition to continue to grow, and ensure that more GSK vaccines and medicines, including innovative new products, will reach more people who need them than ever before. 

That’s why ESG is embedded in GSK’s strategy and supports sustainable performance and long-term growth. There are six ESG focus areas that address what is most material to GSK and the issues that matter to them: access to healthcare, global health and health security, environment, diversity, equity and inclusion, ethical standards and product governance. 

Meanwhile, culture at GSK is something that is the responsibility of everyone to own. It powers the purpose of what they do, drives strategy delivery, and helps make GSK a place where people can thrive. A culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, GSK delivers for patients, shareholders and GSK people.